Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this pilot study, PDLLA scalp microinjections showed improvement in physician-rated Global Aesthetic Improvement Scale scores over 12-24 weeks for 90% of patients with non-scarring alopecia, with no serious adverse events reported, although findings remain preliminary due to methodological limitations.

This case report describes a patient with systemic lupus erythematosus who developed Degos disease and non-scarring alopecia, highlighting dermoscopy's role in diagnosis and treatment prognosis.

In this case report, a 38-year-old woman with Degos disease and non-scarring alopecia experienced significant hair regrowth with the current treatment protocol, highlighting its potential effectiveness in such complex conditions.

This study observed an association between body iron levels and non-scarring diffuse hair loss in non-menopausal women.

In this study, researchers found that although vitamin D deficiency was common among patients with non-scarring alopecia, the prevalence of vitamin D insufficiency was also comparable in the control group, suggesting a need for community-level vitamin D fortification.